Lineage Cell Therapeutics, Inc. - COM (LCTX)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / COM
Number of holders
111
Total Shares
74M
Shares change
-2.16M
Total reported value, excl. options
$181M
Value change
-$5.35M
Put/Call ratio
0.2
Number of buys
41
Number of sells
-48
Price
$2.45
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.